These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 20190241

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.
    Phelan PJ, O'Kelly P, Walshe JJ, Conlon PJ.
    Ren Fail; 2008; 30(4):423-9. PubMed ID: 18569917
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death.
    Ishani A, Solid CA, Weinhandl ED, Gilbertson DT, Foley RN, Collins AJ.
    Nephrol Dial Transplant; 2008 May; 23(5):1682-9. PubMed ID: 18065802
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P.
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
    Liabeuf S, Barreto DV, Barreto FC, Chasseraud M, Brazier M, Choukroun G, Kamel S, Massy ZA.
    Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
    [Abstract] [Full Text] [Related]

  • 31. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.
    Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, McAllister CJ, Shinaberger CS, Gjertson DW, Greenland S.
    Am J Kidney Dis; 2005 Sep; 46(3):489-500. PubMed ID: 16129211
    [Abstract] [Full Text] [Related]

  • 32. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study.
    Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G.
    J Am Soc Nephrol; 2006 Feb; 17(2):546-55. PubMed ID: 16382021
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic.
    Ezekowitz JA, McAlister FA, Armstrong PW.
    Can J Cardiol; 2005 Feb; 21(2):165-71. PubMed ID: 15729416
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.